Villanueva, Evelyn C.

HRN: 27-22-72  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/09/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/09/2025
06/16/2025
IV
2.25g
Q12
Infective Endocarditis, UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary TractCardiovascular    Compliance to guidelines: